Cantor Fitzgerald, L. P. Immunocore Holdings PLC Call Options Transaction History
Cantor Fitzgerald, L. P.
- $90.6 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding IMCR
# of Institutions
147Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$240 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$165 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$143 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$128 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$82.9 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.49B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...